Sinopharm Group Co. Ltd. has issued a formal proxy form and meeting notice to its domestic shareholders ahead of a class meeting set for 10:15 a.m. on Thursday, 18 June 2026. The session will be held in Meeting Room 1401 of Sinopharm Group Building, No. 385 East Longhua Road, Huangpu District, Shanghai, China.

The sole agenda item is a special resolution authorising the Board to obtain a general mandate for the repurchase of the company’s H Shares. The proposal, details of which were previously circulated on 28 May 2026, seeks shareholder approval to empower directors to execute share buy-backs within limits stipulated by applicable regulations.

Domestic shareholders may attend in person or appoint proxies. If designating someone other than the meeting chairman, shareholders must complete and submit the proxy form—together with any notarised authorisation—no later than 24 hours before the meeting’s scheduled start. In cases of joint shareholding, only the first-named holder in the register is entitled to vote.

The meeting is expected to last less than half a day; attendees are responsible for their own transport and accommodation costs and must present valid identification upon arrival.